Serveur d'exploration SRAS - Analysis (2020)

Index « Titre (en) » - entrée « molecular »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
modified < molecular < molecules  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000032 (2020) Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine][Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
000131 (2020) Domenico Benvenuto [Italie] ; Marta Giovanetti [Brésil] ; Marco Salemi [États-Unis] ; Mattia Prosperi [États-Unis] ; Cecilia De Flora [Italie] ; Luiz Carlos Junior Alcantara [Brésil] ; Silvia Angeletti [Italie] ; Massimo Ciccozzi [Brésil]The global spread of 2019-nCoV: a molecular evolutionary analysis
000205 (2020) Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
000245 (2020) Anu Haveri [Finlande] ; Teemu Smura [Finlande] ; Suvi Kuivanen [Finlande] ; Pamela Österlund [Finlande] ; Jussi Hepojoki [Suisse] ; Niina Ikonen [Finlande] ; Marjaana Pitk Paasi [Finlande] ; Soile Blomqvist [Finlande] ; Esa Rönkkö [Finlande] ; Anu Kantele [Finlande] ; Tomas Strandin [Finlande] ; Hannimari Kallio-Kokko [Finlande] ; Laura Mannonen [Finlande] ; Maija Lappalainen [Finlande] ; Markku Broas [Finlande] ; Miao Jiang [Finlande] ; Lotta Siira [Finlande] ; Mika Salminen [Finlande] ; Taneli Puumalainen [Finlande] ; Jussi Sane [Finlande] ; Merit Melin [Finlande] ; Olli Vapalahti [Finlande] ; Carita Savolainen-Kopra [Finlande]Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.
000297 (2020) Abdo A. ElfikyRibavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
000468 (2020) Xiaowei Li [République populaire de Chine] ; Manman Geng [République populaire de Chine] ; Yizhao Peng [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Shemin Lu [République populaire de Chine]Molecular immune pathogenesis and diagnosis of COVID-19
000469 (2020) Hasanain Abdulhameed Odhar [Iraq] ; Salam Waheed Ahjel [Iraq] ; Ali A. Mohammed Ali Albeer [Iraq] ; Ahmed Fadhil Hashim [Iraq] ; Ali Mahmood Rayshan [Iraq] ; Suhad Sami Humadi [Iraq]Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
000470 (2020) A. Bal [France] ; G. Destras [France] ; A. Gaymard [France] ; M. Bouscambert-Duchamp [France] ; M. Valette [France] ; V. Escuret [France] ; E. Frobert [France] ; G. Billaud [France] ; S. Trouillet-Assant [France] ; V. Cheynet [France] ; K. Brengel-Pesce [France] ; F. Morfin [France] ; B. Lina [France] ; L. Josset [France]Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del).
000471 (2020) Bruno Tilocca [Italie] ; Alessio Soggiu [Italie] ; Vincenzo Musella [Italie] ; Domenico Britti [Italie] ; Maurizio Sanguinetti [Italie] ; Andrea Urbani [Italie] ; Paola Roncada [Italie]Molecular basis of COVID-19 relationships in different species: a one health perspective.
000472 (2020) Jiahua He [République populaire de Chine] ; Huanyu Tao [République populaire de Chine] ; Yumeng Yan [République populaire de Chine] ; Sheng-You Huang [République populaire de Chine] ; Yi Xiao [République populaire de Chine]Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2.
000473 (2020) Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Shihui Sun [République populaire de Chine] ; Wanbo Tai [États-Unis] ; Jing Chen [République populaire de Chine] ; Qibin Geng [États-Unis] ; Lei He [République populaire de Chine] ; Yuehong Chen [République populaire de Chine] ; Jianming Wu [États-Unis] ; Zhengli Shi [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] ; Fang Li [États-Unis]Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
000474 (2020) Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie]Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
000475 (2020) Daniel K W. Chu [Hong Kong] ; Yang Pan [République populaire de Chine] ; Samuel M S. Cheng [Hong Kong] ; Kenrie P Y. Hui [Hong Kong] ; Pavithra Krishnan [Hong Kong] ; Yingzhi Liu [Hong Kong] ; Daisy Y M. Ng [Hong Kong] ; Carrie K C. Wan [Hong Kong] ; Peng Yang [République populaire de Chine] ; Quanyi Wang [République populaire de Chine] ; Malik Peiris [Hong Kong] ; Leo L M. Poon [Hong Kong]Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia.
000665 (2020) Jing-Wen Ai [République populaire de Chine] ; Yi Zhang [République populaire de Chine] ; Hao-Cheng Zhang [République populaire de Chine] ; Teng Xu [République populaire de Chine] ; Wen-Hong Zhang [République populaire de Chine]Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned
000993 (2020) Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine]Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
000A03 (2020) Anna S. Fomsgaard [Danemark] ; Maiken Wors E Rosenstierne [Danemark]An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020.
000A17 (2020) Alessio Lorusso [Italie] ; Paolo Calistri [Italie] ; Maria Teresa Mercante [Italie] ; Federica Monaco [Italie] ; Ottavio Portanti [Italie] ; Maurilia Marcacci [Italie] ; Cesare Cammà [Italie] ; Antonio Rinaldi [Italie] ; Iolanda Mangone [Italie] ; Adriano Di Pasquale [Italie] ; Marino Iommarini [Italie] ; Maria Mattucci [Italie] ; Paolo Fazii [Italie] ; Pierluigi Tarquini [Italie] ; Rinalda Mariani [Italie] ; Alessandro Grimaldi [Italie] ; Daniela Morelli [Italie] ; Giacomo Migliorati [Italie] ; Giovanni Savini [Italie] ; Silvio Borrello [Italie] ; Nicola D'Alterio [Italie]A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy
000A78 (2009) Host Biomarkers and Paediatric Infectious Diseases: From Molecular Profiles to Clinical Application

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "molecular" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "molecular" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    molecular
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021